Flucinar ointment for outside. approx. 0.025% tube 15g
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Poland
Package quantity, pcs
one
Release form, composition and packaging
Ointment for external use 0.025% white or almost white, translucent, oily.
1 g
fluocinolone acetonide 250 mcg
propylene glycol - 150 mg, ethanol - 150 mg, disodium edetate - 0.25 mg, citric acid - 0.1 mg, methyl parahydroxybenzoate - 1.5 mg, propyl parahydroxybenzoate - 0.8 mg, carbomer 980 - 9 mg, trolamine - 1.8 mg, purified water - up to 1 g.
15 g - aluminum tubes (1) - cardboard packs.
pharmachologic effect
GCS for external use.
It has anti-inflammatory, anti-allergic, anti-exudative and antipruritic effects.
Reduces the appearance or eliminates the inflammatory skin reaction.
Indications for use
Psoriasis, lichen planus, seborrheic dermatitis, eczema of various origins and localization (including eczema in children), neurodermatitis, pruritus of various origins, allergic skin diseases, discoid lupus erythematosus, 1st degree burns, sunburn, insect bites.
Contraindications for use
Bacterial, viral, fungal skin diseases, skin tuberculosis, skin manifestations of syphilis, extensive psoriatic plaques, anogenital itching, trophic ulcers of the leg associated with varicose veins, skin tumors, pregnancy.
Dosage regimen
Applied externally 1-3 times / day, depending on the dosage form used.
Side effect
Possibly: telangiectasias, post-steroidal vascular purpura, skin atrophy, skin stretching, hirsutism, hypertrichosis, perioral dermatitis, secondary infectious skin lesions
with prolonged use and / or when applied to large surfaces, systemic side effects are possible.
Application during pregnancy and lactation
Contraindicated in pregnancy.
special instructions
In the case of use with ordinary or rosacea, an exacerbation of the course of the disease is possible.
Use with caution in infants and girls during puberty.
Fluocinolone acetonide is compatible with antimicrobial agents.
Name ENG
FLUCINAR
Clinical and pharmacological group
GCS for external use
ATX code
Fluocinolone acetonide
Dosage
0.025% x 15g
INN / Active ingredient
fluocinolone acetonide
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Poland
Package quantity, pcs
one
Vacation conditions
Without recipe
Brand name
Flucinar
The amount of the dosage form in the primary package
15 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Topical glucocorticosteroid
Anatomical and therapeutic characteristics
D07AC04 Fluocinolone acetonide
Dosage form
Ointment for external use
Item weight, g
15
The target audience
Adult
Expiration date in days
1095
Package weight, g
twenty